Andere Sprachen Augmedix, Inc.

Aktien

A2QHRH

US05105P1075

AUGX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 10.05.2024			% 5 Tage	% 1. Jan.
2,225 ^USD	-10,82 %		-17,90 %	-61,97 %

24.04.	Augmedix bringt das branchenweit erste vollautomatische, GenAI-gestützte Produkt für die medizinische Dokumentation in Notaufnahmen auf den Markt	CI
12.04.	Augmedix-Insider verkaufte Aktien im Wert von $369.285, laut einer aktuellen SEC-Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Augmedix to Participate in Upcoming Investor Conferences in May and June 2024	03.05.
Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024	30.04.
Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List	25.04.
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments	24.04.
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments	24.04.
Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing	12.04.
North American Morning Briefing : Traders Await -2-	10.04.
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care	09.04.
Augmedix, Inc. Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care	09.04.
Augmedix Insider Sold Shares Worth $454,454, According to a Recent SEC Filing	05.04.
Augmedix Insider Sold Shares Worth $380,108, According to a Recent SEC Filing	04.04.
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide	04.04.
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide	04.04.
Top Midday Gainers	19.03.
Augmedix Shares Surge 15% Premarket Tuesday as Revenue Growth Beats Expectations, Gross Margins Expand in Q4	19.03.
Earnings Flash (AUGX) AUGMEDIX Reports Q4 Revenue $12.7M, vs. Street Est of $12.4M	18.03.
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023	18.03.
Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	18.03.
Augmedix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18.03.
Augmedix Provides Revenue Guidance for the Year 2024	18.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Augmedix, Inc.

Aktien

A2QHRH

US05105P1075

AUGX

Andere Sprachen

Filter